Strides Pharma Science logo

Strides Pharma Science CEO, MD, chairman, board of directors and AGM

NSE: STARBSE: 532531Pharmaceuticals & BiotechnologySmall Cap

Formerly Strides Shasun
Last close ₹1,014.80up ₹16.40 (1.64%)BSE ₹1,012.15

Share price at the NSE close on 23 Oct 2026. Previous close ₹998.40.

52-week range of traded prices to 23 Oct 2026
₹768.65Low, 29 Jan 2026₹1,260.90High, 21 Sep 2026
Market cap
₹9,354 Cr580th largest listed
P/E
15.2
P/B
3.0
Dividend yield
0.49%
ROE
21.7%
ROCE
15.1%
Debt to equity
0.53
Volume, NSE
3,12,38541.2% delivered

Strides Pharma Science board of directors

At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonArun Kumar PillaiRelated to the promoter
  • Managing director and CEOBadree Komandur
  • Company Secretary and Compliance OfficerManjula Ramamurthy

9 directors5 independent2 executive2 non-executive

  • Arun Kumar Pillai · ChairpersonNon-executive · joined Jun 1990 · reappointed Apr 2025 · 3 listed boards · 1 committee seat
  • Kausalya SanthanamIndependent · joined Dec 2019 · reappointed Dec 2024 · 78 months as independent · 2 listed boards · 2 as independent · 4 committee seats, 2 as chair
  • Mukta AroraIndependent · joined Feb 2025 · reappointed Feb 2025 · 16 months as independent · 1 listed board · 1 as independent · 1 committee seat
  • Homi R KhusrokhanIndependent · joined May 2017 · reappointed May 2022 · 109 months as independent · 2 listed boards · 2 as independent · 2 committee seats, 2 as chair
  • Ameet Pratapsinh HarianiIndependent · joined Feb 2024 · reappointed Feb 2024 · 28 months as independent · 5 listed boards · 5 as independent · 8 committee seats, 2 as chair
  • Subir ChakrabortyIndependent · joined Jun 2024 · reappointed Jun 2024 · 24 months as independent · 2 listed boards · 2 as independent · 2 committee seats
  • Badree Komandur · Managing director and CEOExecutive · joined May 2017 · reappointed Jun 2024 · 1 listed board
  • Aditya Arun KumarNon-executive · joined Jun 2024 · reappointed Jun 2026 · 1 listed board
  • Venkata Seetharama Raju PakalapatiExecutive · joined Jun 2026 · reappointed Jun 2026 · 1 listed board

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 27 Jun 20269 of 9 present5 independent · 7 days in between
    • 19 Jun 20269 of 9 present5 independent · 31 days in between
    • 18 May 20268 of 8 present5 independent · 107 days in between
    • 30 Jan 20268 of 8 present5 independent

  • Audit Committee

    Chair Homi R Khusrokhan

    Kausalya Santhanam, Ameet Pratapsinh Hariani, Subir Chakraborty, Mukta Arora

    • 19 Jun 20265 of 5 present5 independent · 31 days in between
    • 18 May 20265 of 5 present5 independent · 107 days in between
    • 30 Jan 20265 of 5 present5 independent

  • Nomination and remuneration committee

    Chair Ameet Pratapsinh Hariani

    Homi R Khusrokhan, Kausalya Santhanam, Subir Chakraborty, Mukta Arora, Arun Kumar Pillai

    • 19 Jun 20266 of 6 present5 independent · 31 days in between
    • 18 May 20266 of 6 present5 independent · 186 days in between
    • 12 Nov 20256 of 6 present5 independent

  • Stakeholders Relationship Committee

    Chair Kausalya Santhanam

    Arun Kumar Pillai, Ameet Pratapsinh Hariani, Subir Chakraborty

    • 18 May 20264 of 4 present3 independent · 107 days in between
    • 30 Jan 20264 of 4 present3 independent

  • Risk Management Committee

    Chair Homi R Khusrokhan

    Kausalya Santhanam, Badree Komandur, Ameet Pratapsinh Hariani, Subir Chakraborty, Aditya Arun Kumar, Mukta Arora, Sormistha Gosh, Venkata Seetharama Raju Pakalapati

    No meeting listed in the filing.

  • Corporate Social Responsibility Committee

    Chair Kausalya Santhanam

    Homi R Khusrokhan, Arun Kumar Pillai, Aditya Arun Kumar

    • 18 May 20263 of 3 present2 independent · 107 days in between
    • 30 Jan 20263 of 3 present2 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • BSR & Co., LLPPeer-review certificate valid to Mar 2027

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Strides Pharma Science AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Strides Pharma Science dividend history

Annual general meeting, 14 Aug 2026

97,939 shareholders on the register on 7 Aug 2026; present: 14 promoters and 60 others; votes counted by Gigi Joseph K J / Joseph and Chacko LLP.The company's voting result (opens in a new tab)

  1. Adoption of Audited Financial Statements of the Company (including consolidated financial statements) for the financial year ended March 31, 2026.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 73.11% · promoters 100.00% · institutions 85.97% · other public 26.10%

  2. Declaration of Final Dividend for the Financial Year ended March 31, 2026.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 73.40% · promoters 100.00% · institutions 86.62% · other public 26.10%

  3. Re-appointment of Retiring Director
    Ordinary
    97.92% for2.08% against

    Against: promoters 0.00% · institutions 3.92% · other public 0.00%

    Turnout: all 72.02% · promoters 95.06% · institutions 86.62% · other public 26.10%

  4. Payment of Commission to Non-Executive Directors of the Company in the event of inadequacy of profit.
    Special
    99.73% for0.27% against

    Against: promoters 0.00% · institutions 0.51% · other public 0.01%

    Turnout: all 72.76% · promoters 97.70% · institutions 86.62% · other public 26.10%

  5. Appointment of Mr. Aditya Arun Kumar as Non‑Executive Director of the Company.
    Ordinary
    98.95% for1.05% against

    Against: promoters 0.00% · institutions 2.01% · other public 0.00%

    Turnout: all 73.34% · promoters 99.77% · institutions 86.62% · other public 26.10%

  6. Appointment of Mr. Venkata Seetharama Raju Pakalapati as Executive Director.
    Special
    99.55% for0.45% against

    Against: promoters 0.00% · institutions 0.86% · other public 0.00%

    Turnout: all 73.35% · promoters 100.00% · institutions 86.62% · other public 25.92%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 7 Aug 2025, 5 resolutions

94,548 shareholders on the register on 31 Jul 2025; present: 16 promoters and 49 others; votes counted by Gigi Joseph K J / Joseph and Chacko LLP.The company's voting result (opens in a new tab)

  1. Adoption of Audited Financial Statements of the Company (including consolidated financial statements) for the financial year ended March 31, 2025
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 64.76% · promoters 100.00% · institutions 78.41% · other public 13.29%

  2. Declaration of Final Dividend for the Financial Year ended March 31, 2025
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 65.01% · promoters 100.00% · institutions 79.02% · other public 13.29%

  3. Re-appointment of Mr. Aditya Arun Kumar, retiring Director
    Ordinary
    99.44% for0.56% against

    Against: promoters 0.00% · institutions 1.10% · other public 0.01%

    Turnout: all 65.01% · promoters 100.00% · institutions 79.02% · other public 13.29%

  4. Appointment of M/s V. Sreedharan & Associates, as Secretarial Auditor of the Company
    Ordinary
    99.62% for0.38% against

    Against: promoters 0.00% · institutions 0.74% · other public 0.00%

    Turnout: all 65.01% · promoters 100.00% · institutions 79.02% · other public 13.29%

  5. Remuneration payable to M/s. Rao, Murthy & Associates, Cost Auditors of the Company for FY 2025-26
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.02%

    Turnout: all 65.01% · promoters 100.00% · institutions 79.02% · other public 13.29%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 19 Mar 2025, 2 resolutions

1,03,321 shareholders on the register on 14 Feb 2025; votes counted by Gigi Joseph K J / Joseph and Chacko LLP.The company's voting result (opens in a new tab)

  1. Appointment of Ms. Mukta Arora as Independent Director of the Company
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 62.42% · promoters 99.98% · institutions 74.33% · other public 13.06%

  2. Appointment of Mr. Arun Kumar as Non–Executive Director and Chairperson of the Board
    Ordinary
    98.14% for1.86% against

    Against: promoters 0.00% · institutions 3.59% · other public 0.02%

    Turnout: all 60.30% · promoters 92.16% · institutions 74.33% · other public 13.06%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 27 Nov 2024, 1 resolution

The company's voting result (opens in a new tab)

  1. Re-appointment of Dr. Kausalya Santhanam (DIN: 06999168) as an Independent Director of the Company
    Special
    87.96% for12.04% against

    Against: promoters 0.00% · institutions 21.23% · other public 1.79%

    Turnout: all 71.39% · promoters 100.00% · institutions 83.20% · other public 21.19%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 25 Sep 2024, 5 resolutions

Present: 12 promoters and 52 others.The company's voting result (opens in a new tab)

  1. Adoption of Audited Financial Statements for the Financial Year ended March 31, 2024
    Ordinary
    98.30% for1.70% against

    Against: promoters 0.00% · institutions 3.13% · other public 0.00%

    Turnout: all 68.91% · promoters 100.00% · institutions 77.65% · other public 21.46%

  2. Declaration of Final Dividend for the Financial Year ended March 31, 2024
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 68.97% · promoters 100.00% · institutions 77.79% · other public 21.46%

  3. Re-appointment of Mr. Badree Komandur, retiring Director
    Ordinary
    99.86% for0.14% against

    Against: promoters 0.00% · institutions 0.26% · other public 0.03%

    Turnout: all 68.97% · promoters 100.00% · institutions 77.79% · other public 21.46%

  4. Remuneration payable to M/s. Rao, Murthy & Associates, Cost Auditors of the Company for the Financial Year ended March 31, 2024
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 68.97% · promoters 100.00% · institutions 77.79% · other public 21.46%

  5. Remuneration payable to M/s. Rao, Murthy & Associates, Cost Auditors of the Company for the Financial Year ended March 31, 2025
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.01%

    Turnout: all 68.97% · promoters 100.00% · institutions 77.79% · other public 21.46%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Meeting called by the tribunal, 10 Sep 2024, 1 resolution

Present: 12 promoters and 33 others.The company's voting result (opens in a new tab)

  1. To consider and if thought fit, approve, with or without modification(s), the Scheme of Arrangement amongst Strides Pharma Science Limited (“Strides” or “Transferor Company 1” or “Demerged Company 1”) and Steriscience Specialties Private Limited (“Steriscience” or “Transferor Company 2” or “Demerged Company 2”) and Onesource Specialty Pharma Limited (“Onesource” or “Transferee Company” or “Resulting Company”) and their respective shareholders.MoreLess
    SpecialPromoters have an interest in it
    87.17% for12.83% against

    Against: promoters 0.00% · institutions 23.89% · other public 1.24%

    Turnout: all 71.88% · promoters 100.00% · institutions 79.41% · other public 30.05%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 26 Jul 2024, 3 resolutions

The company's voting result (opens in a new tab)

  1. Appointment of Mr. Subir Chakraborty (DIN: 00130864) as Independent Director of the Company
    Special
    99.99% for0.01% against

    Against: promoters 0.00% · institutions 0.01% · other public 0.07%

    Turnout: all 65.24% · promoters 100.00% · institutions 79.19% · other public 13.12%

  2. Appointment of Mr. Badree Komandur (DIN: 07803242) as Managing Director and Group Chief Executive Officer of the Company
    Special
    90.86% for9.13% against

    Against: promoters 0.00% · institutions 16.76% · other public 0.06%

    Turnout: all 65.24% · promoters 100.00% · institutions 79.19% · other public 13.12%

  3. Appointment of Mr. Aditya Arun Kumar (DIN: 06999081) as Executive Director – Business Development of the Company
    Special
    90.87% for9.13% against

    Against: promoters 0.00% · institutions 16.76% · other public 0.06%

    Turnout: all 65.24% · promoters 100.00% · institutions 79.19% · other public 13.11%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 27 Apr 2024, 1 resolution

The company's voting result (opens in a new tab)

  1. Appointment of Mr. Ameet P Hariani (DIN: 00087866) as Independent Director of the Company
    Special
    99.00% for1.00% against

    Against: promoters 0.00% · institutions 1.75% · other public 0.41%

    Turnout: all 62.47% · promoters 100.00% · institutions 83.59% · other public 3.27%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it

Mutual fund votes, meeting of 14 Aug 2026, 2 fund houses so far (houses' deadline to file 15 Oct 2026)

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Adoption of Audited Financial Statements of the Company (including consolidated financial statements) for the financial year ended March 31, 2026.
    2 for0 against
  • Declaration of Final Dividend for the Financial Year ended March 31, 2026.
    2 for0 against
  • Re-appointment of Retiring Director
    1 for0 against
  • Payment of Commission to Non-Executive Directors of the Company in the event of inadequacy of profit.
    Against Angel One Mutual Fund
    • Angel One Mutual FundGovernance & Transparency concern: Inadequate disclosures; the Company has not provided adequate justification for the significant increase in proposed commission limits. Proposed commission appears excessive.
    1 for1 against
  • Appointment of Mr. Aditya Arun Kumar as Non‑Executive Director of the Company.
    2 for0 against
  • Appointment of Mr. Venkata Seetharama Raju Pakalapati as Executive Director.
    2 for0 against
1 proposal not matched to one resolution
  • Reappoint Arun Kumar (DIN: 00084845) as Non-Executive Non-Independent Director, liable to retire by rotation
    1 for0 against

Mutual fund votes, meeting of 7 Aug 2025, 12 fund houses

  • Adoption of Audited Financial Statements of the Company (including consolidated financial statements) for the financial year ended March 31, 2025
    12 for0 against
  • Declaration of Final Dividend for the Financial Year ended March 31, 2025
    12 for0 against
  • Re-appointment of Mr. Aditya Arun Kumar, retiring Director
    12 for0 against
  • Appointment of M/s V. Sreedharan & Associates, as Secretarial Auditor of the Company
    Against Angel One Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund
    • Angel One Mutual FundTransparency concern: The Company has not disclosed the audit fee paid to the outgoing Secretarial Auditor; therefore, it is not possible to determine whether there has been a material change in the audit fee.
    • Groww Mutual Fund, Motilal Oswal Mutual FundComplaint with Law. No concern on the merits of proposed Auditors. Transparency concern: The Company has not disclosed the audit fee paid to the outgoing Secretarial Auditor; therefore, it is not possible to determine whether there has been a material change in the audit fee..
    9 for3 against
  • Remuneration payable to M/s. Rao, Murthy & Associates, Cost Auditors of the Company for FY 2025-26
    12 for0 against
6 earlier meetings

Mutual fund votes, meeting of 19 Mar 2025, 10 fund houses

  • Appointment of Ms. Mukta Arora as Independent Director of the Company
    10 for0 against
  • Appointment of Mr. Arun Kumar as Non–Executive Director and Chairperson of the Board
    Against Groww Mutual Fund, Motilal Oswal Mutual Fund
    • Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance Concern: Chairman related to Executive Director
    8 for2 against

Mutual fund votes, meeting of 27 Nov 2024, 12 fund houses

  • Re-appointment of Dr. Kausalya Santhanam (DIN: 06999168) as an Independent Director of the Company
    Against Bandhan Mutual Fund, Groww Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, quant Mutual Fund
    • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundRe-appointment Compliant with law. Governance Concern: The proposed term will lead to prolonged association.
    • Mirae Asset Mutual FundAssociation with the group is more than ten years
    • quant Mutual FundRes 1 Vote: AGAINST Explanation: Re-appointment Compliant with law. Governance Concern: The proposed term will lead to prolonged association. Her association with the Group will exceed 10 years due to not served requisite cooling off period. Appointment of an Independent Director who has had prolonged association with the Company/Group is not indicative of a good governance practice.
    7 for5 against

Mutual fund votes, meeting of 25 Sep 2024, 10 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Adoption of Audited Financial Statements for the Financial Year ended March 31, 2024
    Against Groww Mutual Fund
    • Groww Mutual FundUnqualified financial statements. Compliant with the Indian Accounting Standards. Governance Concern: Material unaudited statements forming part of the consolidated financial statements of the Company.
    8 for1 against
  • Declaration of Final Dividend for the Financial Year ended March 31, 2024
    9 for0 against
  • Re-appointment of Mr. Badree Komandur, retiring Director
    9 for0 against
  • Remuneration payable to M/s. Rao, Murthy & Associates, Cost Auditors of the Company for the Financial Year ended March 31, 2024
    8 for0 against
  • Remuneration payable to M/s. Rao, Murthy & Associates, Cost Auditors of the Company for the Financial Year ended March 31, 2025
    8 for0 against
3 proposals not matched to one resolution
  • 1. Adoption of Audited Financial Statements for the Financial Year ended March 31, 2024 2. Declaration of Final Dividend for the Financial Year ended March 31, 2024 3. Re-appointment of Mr. Badree Komandur, retiring Director 4. Remuneration payable to M/s. Rao, Murthy & Associates, Cost Auditors of the Company for the Financial Year ended March 31, 2024 5. Remuneration payable to M/s. Rao, Murthy & Associates, Cost Auditors of the Company for the Financial Year ended March 31, 2025MoreLess
    1 for0 against
  • Ratify remuneration of Rs. 350,000 (excluding out-of-pocket expenses and reimbursements) to Rao, Murthy & Associates, as cost auditors for FY24
    1 for0 against
  • Ratify remuneration of Rs. 400,000 (excluding out-of-pocket expenses and reimbursements) to Rao, Murthy & Associates, as cost auditors for FY25
    1 for0 against

Mutual fund votes, meeting of 10 Sep 2024, 9 fund houses

  • To consider and if thought fit, approve, with or without modification(s), the Scheme of Arrangement amongst Strides Pharma Science Limited (“Strides” or “Transferor Company 1” or “Demerged Company 1”) and Steriscience Specialties Private Limited (“Steriscience” or “Transferor Company 2” or “Demerged Company 2”) and Onesource Specialty Pharma Limited (“Onesource” or “Transferee Company” or “Resulting Company”) and their respective shareholders.MoreLess
    Against Groww Mutual Fund
    • Groww Mutual FundCompliant with law. Transparency and Governance Concern: Considering the Revenue & EBITDA multiples, the Valuation of the Resulting Company appears in higher side in compare to that of Demerged Undertakings, no justification / rationale provided.
    8 for1 against

Mutual fund votes, meeting of 26 Jul 2024, 5 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • Appointment of Mr. Subir Chakraborty (DIN: 00130864) as Independent Director of the Company
    4 for0 against
  • Appointment of Mr. Badree Komandur (DIN: 07803242) as Managing Director and Group Chief Executive Officer of the Company
    4 for0 against
  • Appointment of Mr. Aditya Arun Kumar (DIN: 06999081) as Executive Director – Business Development of the Company
    4 for0 against
1 proposal not matched to one resolution
  • 1. Appointment of Mr. Subir Chakraborty (DIN: 00130864) as Independent Director of the Company 2. Appointment of Mr. Badree Komandur (DIN: 07803242) as Managing Director and Group Chief Executive Officer of the Company 3. Appointment of Mr. Aditya Arun Kumar (DIN: 06999081) as Executive Director – Business Development of the CompanyMoreLess
    1 for0 against

Mutual fund votes, meeting of 27 Apr 2024, 5 fund houses

  • Appointment of Mr. Ameet P Hariani (DIN: 00087866) as Independent Director of the Company
    5 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

At most 1 complaint open, quarter to Sep 2025.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
No
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.